CRA-026440 hydrochloride

Research use only, not for human use.

CRA-026440 hydrochloride is a potent and broad-spectrum HDAC inhibitor.

CRA-026440 hydrochloride is a potent, broad-spectrum HDAC (HDAC) inhibitor. The Ki values against recombinant HDAC isoenzymes HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, and HDAC10 are 4 nM, 14 nM, 11 nM, 15 nM, 7 nM, and 20 nM respectively. CRA-026440 hydrochloride shows antitumor and antiangiogenic activities. CRA-026440 (hydrochloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

Western Blot Analysis Cell Line:HCT116 cells Concentration:0.1 μM, 0.5 μM, 1 μM, 5 μM, 10 μM Incubation Time:18 hours Result:Resulted in the accumulation of both acetylated histones and acetylated tubulin. Induced expression of the cyclin-dependent kinase inhibitor p21Cip1/WAF1.

Animal Model:HCT-116 tumor-bearing nude mice Dosage:100 mg/kg Administration:i.v.; daily; for three consecutive days Result:Resulted in a statistically significant reduction in tumor growth.

——

Cell Cycle/DNA Damage

HDAC

HDAC

——

——

847459-98-7

456.92

C23H25ClN4O4

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (218.86 mM; Ultrasonic )

Cl.CN(C)CCOc1ccc2[nH]c(cc2c1)C(=O)NCC#Cc1ccc(cc1)C(=O)NO

——

(-20℃)

With Ice Pack

≥ 2 years